RobertE.StrongDO

PubMed

• 33 citations
  Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine
  Barrie K. Marchant, Frederick W. Reimherr, Corinne Halls, Robert E. Strong, Douglas G. Kondo, Poonam Soni, Robison, R. J., Erika D. Williams, Reid J. Robison> ;Attention Deficit and Hyperactivity Disorders. 2011 Mar 27
• 15 citations
  OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.
  Barrie K. Marchant, Frederick W. Reimherr, Corinne Halls, Robert E. Strong> ;Annals of Clinical Psychiatry. 2010 Aug 1
• 16 citations
  Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate.
  Erika D. Williams, Frederick W. Reimherr, Robert E. Strong, Corinne Halls, Poonam Soni, Phillip Gale, Robison, R. J., Barrie K. Marchant, Reid J. Robison> ;Annals of Clinical Psychiatry. 2010 May 1
• 13 citations
  Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.
  Frederick W. Reimherr, Phillip Gale, Barrie K. Marchant, Erika D. Williams, Poonam Soni, Robert E. Strong, > ;Annals of Clinical Psychiatry. 2010 May 1
• 16 citations
  Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD.
  Frederick W. Reimherr, Barrie K. Marchant, Robert E. Strong, Corinne Halls, Poonam Soni> ;Annals of Clinical Psychiatry. 2010 May 1
• 51 citations
  Narrow‐band blue‐light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms
  Robert E. Strong, Barrie K. Marchant, Frederick W. Reimherr, Erika D. Williams, Poonam Soni, Ruth Mestas> ;Depression and Anxiety. 2009 Mar 1
• 127 citations
  A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional di...
  Frederick W. Reimherr, Robert E. Strong, Ruth Mestas, Poonam Soni, Barrie K. Marchant> ;The Journal of Clinical Psychiatry. 2007 Jan 15
• 61 citations
  Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.
  Roy H. Perlis, Charles M. Beasley, James D. Wines, Roy N. Tamura, Cristina Cusin, Deborah L. Shear, Jay D. Amsterdam, Frederick M. Quitkin, Robert E. Strong, Jerrold F...> ;Psychotherapy and Psychosomatics. 2007 Jan 1
• 29 citations
  Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial.
  Frederick W. Reimherr, Dawson W. Hedges, Robert E. Strong, Barrie K. Marchant, Erika D. Williams> ;Neuropsychiatric Disease and Treatment. 2005 Sep 1
• 137 citations
  Emotional dysregulation in adult ADHD and response to atomoxetine.
  Frederick W. Reimherr, Robert E. Strong, Dawson W. Hedges, Lenard A. Adler, Thomas J. Spencer, Scott A. West, Poonam Soni> ;Biological Psychiatry. 2005 Jul 15
• 56 citations
  Borderline personality disorder in patients with bipolar disorder and response to lamotrigine.
  Gilbert A. Preston, Barrie K. Marchant, Robert E. Strong, Dawson W. Hedges> ;Journal of Affective Disorders. 2004 Apr 1
• 26 citations
  Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depression.
  Frederick W. Reimherr, Robert E. Strong, Barrie K. Marchant, Dawson W. Hedges, Paul H. Wender> ;The Journal of Clinical Psychiatry. 2001 Jan 8
• 43 citations
  An open trial of nefazodone in adult patients with generalized anxiety disorder.
  Dawson W. Hedges, Frederick W. Reimherr, Robert E. Strong, Corinne Halls, Rust C> ;Psychopharmacology Bulletin. 1996 Jan 1
• 60 citations
  An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder
  Dawson W. Hedges, Frederick W. Reimherr, Robert E. Strong, Paul H. Wender> ;Psychopharmacology Bulletin. 1995 Jan 1
• Join now to see all